Report Feature
The future of the insulin delivery device market looks promising with opportunities in the patients/homecare and hospitals & clinics industries. The global insulin delivery device market is expec
ted to grow with a CAGR of 9% from 2019 to 2024. The major growth drivers for this market are growing geriatric population base, high adoption of sedentary lifestyle and growing awareness of diabetes treatment, technological advancements in insulin delivery devices, and rising awareness of advanced insulin delivery devices.A report of more than 150 pages is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of insulin delivery device market report download the report brochure
The study includes the insulin delivery device market size and forecast for the global insulin delivery device market through 2024, segmented by product type, end user, and region as follows:
By Product Type [$M shipment analysis for 2013 – 2024]:
- Insulin Syringe
- Insulin Pens
- Insulin Pumps
- Pen Needles
- Other Devices
By End User [$M shipment analysis for 2013 – 2024]:
- Patients/Homecare
- Hospitals & Clinics
By Region [$M shipment analysis for 2013 – 2024]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
-
Asia Pacific
- China
- India
- Japan
-
Rest of the World
- Brazil
Some of the insulin delivery devices companies profiled in this report include Becton Dickinson and Company, Novo Nordisk A/S, Medtronic, Sanofi, ELI Lilly and Company, Ypsomed, Animas, Tandem Diabetes Care, Insulet, and Biocon.
Some of the features of this report:
- Market size estimates: Global insulin delivery device market size estimation in terms of value ($M) shipment.
- Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
- Segmentation analysis: Global market size by product type, end user, and region.
- Regional analysis: Global insulin delivery device market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth opportunities: Analysis on growth opportunities in different applications and regions for insulin delivery devices in the global insulin delivery device market.
- Strategic analysis: This includes M&A, new product development, and competitive landscape for, insulin delivery devices in the global insulin delivery device market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Table of Contents
1. Executive Summary 2. Market Background and Classifications 2.1: Introduction, Background, and Classifications 2.2: Supply Chain 2.3: Industry Drivers and Challenges
5. Competitor Analysis 5.1: Product Portfolio Analysis 5.2: Market Share Analysis 5.3: Operational Integration 5.4: Geographical Reach 5.5: Porter’s Five Forces Analysis
7. Company Profiles of Leading Players 7.1: Becton 7.2: Dickinson and Company 7.3: Novo Nordisk A/S 7.4: Medtronic 7.5: Sanofi 7.6: ELI Lilly and Company 7.7: Ypsomed 7.8: Animas 7.9: Tandem Diabetes Care 7.10: Insulet Corporation 7.11: Biocon
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising potential, high-growth opportunities for the global insulin delivery device market by product type (insulin syringe, insulin pens, insulin pumps, pen needles, and other devices), end user (patients/homecare and hospitals and clinics), and region (North America, Europe, Asia-Pacific, and Rest of the World)?
- • Which segments will grow at a faster pace and why?
- • Which regions will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the drivers and challenges of the insulin delivery device market?
- • What are the business risks and threats to the insulin delivery device market?
- • What are emerging trends in this insulin delivery device market and the reasons behind them?
- • What are some changing demands of customers in the insulin delivery device market?
- • What are the new developments in the insulin delivery device market? Which companies are leading these developments?
- • Who are the major players in this insulin delivery device market? What strategic initiatives are being implemented by key players for business growth?
- • What are some of the competitive products and processes in this insulin delivery devices area and how big of a threat do they pose for loss of market share via material or product substitution?
- • What M & A activities have taken place in the last 5 years in insulin delivery device market?
